×

BRIEF-Human Genome drops in premarket after US FDA staff findings on benlysta

NEW YORK, Nov 12 (Reuters) - Human Genome Sciences Inc: * Drops 3.7 percent premarket after US FDA staff findings on lupus drug benlysta (Wall Street Newsdesk Telephone: +1 646-223-6110) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved.

The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.